Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 7.78M P/E - EPS this Y - Ern Qtrly Grth -
Income -4.3M Forward P/E - EPS next Y - 50D Avg Chg -37.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -74.00%
Dividend N/A Price/Book 0.67 EPS next 5Y - 52W High Chg -94.00%
Recommedations - Quick Ratio 0.26 Shares Outstanding 358.45M 52W Low Chg 37.00%
Insider Own 1.46% ROA -16.44% Shares Float 353.21M Beta -0.22
Inst Own 0.04% ROE -45.13% Shares Shorted/Prior -/- Price 0.02
Gross Margin - Profit Margin - Avg. Volume 574,206 Target Price -
Oper. Margin - Earnings Date May 28 Volume 477,153 Change 0.00%
About REVIVE THERAPEUTICS LTD

Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers cannabinoid pharmaceutical portfolio that focuses on rare inflammatory diseases. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and COVID-19; Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases; and cannabidiol for treating autoimmune hepatitis and ischemia and reperfusion injury from organ transplantation. The company is based in Toronto, Canada.

REVIVE THERAPEUTICS LTD News
04/02/24 Revive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine Use Disorder
03/27/24 Revive Therapeutics Submits Type C Meeting Request Package to FDA for Clinical Study of Bucillamine to Treat Long COVID
03/19/24 Revive Therapeutics To Submit Type C Meeting Request with FDA for Bucillamine to Treat Long COVID
03/12/24 Revive Therapeutics Provides Corporate Update
02/26/24 Revive Therapeutics Ltd. Announces Closing of the Second and Final Tranche of Its Private Placement for Gross Proceeds of $1,187,110
02/01/24 Revive Therapeutics Explores the Use of Bucillamine for Long COVID
01/31/24 Revive Therapeutics Ltd. Announces Closing of the First Tranche of Its Private Placement for Gross Proceeds of $913,500
01/24/24 Revive Therapeutics Ltd. Announces Offering of Up to $3 Million
01/16/24 Revive Therapeutics Provides Update Evaluating Bucillamine for Nerve Agent Exposure with Defence Research and Development Canada
01/10/24 Revive Therapeutics Successfully Completes Development of a Novel Lyophilized Formulation of Bucillamine
12/20/23 Revive Therapeutics Announces Results of Annual General and Special Meeting of Shareholders
07:00 AM Revive Therapeutics Collaborates with Attwill Medical Solutions for the Clinical and Commercial Development of a Novel Lyophilized Formulation of Bucillamine
11/21/23 Revive Therapeutics Provides Update of Novel Bucillamine Formulation Development
11/06/23 Revive Therapeutics Enters into Worldwide Exclusive Agreement with Lawson Health Research Institute to Develop and Commercialize a Novel Long COVID Rapid Test
10/17/23 Revive Therapeutics Enters into Agreement with Defence Research and Development Canada for Evaluating Bucillamine for Nerve Agent Exposure
08/22/23 Revive Therapeutics Announces Initiation of Novel Bucillamine Formulation Development
07/28/23 Revive Therapeutics Announces Filing of Patent for Bucillamine in the Treatment of Exposure to Chemical Warfare Agents
07/06/23 Revive Therapeutics Announces Results of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19
05/30/23 Revive Therapeutics Provides Update of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19
05/02/23 Revive Therapeutics Announces Data Safety Monitoring Board Meeting Date on Phase 3 Clinical Study of Bucillamine in the Treatment of COVID-19
RVVTF Chatroom

User Image ResearchTrd Posted - 1 day ago

$RVVTF #BULLISH....Going to go mainstream by momentum just like weed....#RVVTF is going to lift off and keep going... https://www.foxnews.com/lifestyle/psychedelic-drug-retreat-reports-183-spike-bookings-health-experts-cite-downside

User Image thegreen92 Posted - 1 week ago

$RVVTF not much happens on this board?! Opened a nice position here today, so now that I have, the stock price can officially sky rocket up!! 🥳😆 thank you and hello to all!

User Image drpower2000 Posted - 1 week ago

@aricray @Multipliers you keep posting about investors so you are telling me that any big investor has a 100% return rate on every investment? If you think that, I have a $1M pet rock I want to sell you. Plain and simple big investor get investments WRONG all the time. The key is to get bigger win than loses. Obviously they expect a return, but it doesn’t mean they will get it. Also they may be satisfied with a 300% return. Where that won’t even get most people on here back to there cost basis. So this is FAR from guaranteed. At this point I give it a 20% odds and that being generous based on most $ARTL $CRBP $GWPH $RVVTF $SKYE tech trial results.

User Image BaronXXII Posted - 1 week ago

@allRS up until last 2 years I've had a better ROI than Buffet. Because of: $XXII $RVVTF (p&d, friends involved. Mea culpa.) Biden fucked ALL my drone stocks by reversing the ban on Chinese drones (no kidding!) Biden ALSO fucked ALL of my lithium plays by allowing Chinese lithium in our market WITHOUT a fucking tarrif... (It's beyond incompetent or politics, he's criminally involved, imo) And finally, there's $INTEQ BK reorg. We got effed by a BK judge - who tf let's a BK company use their assets to BUY another company, switch which entities are covered by the BK filing, gives ALL assets to NEW bondholders and then STILL wipes out shareholders?? That effer should be behind bars! Ok. I'm going back to my vodka now. 💯💩

User Image PREPAREyourRUMP Posted - 2 weeks ago

$RVVTF too believe I’d never see this fall lower than .20 usd…lol

User Image Mystockdaily Posted - 2 weeks ago

$RVVTF Breaking News!! Revive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine Use Disorder https://finance.yahoo.com/news/revive-therapeutics-provides-psilocybin-clinical-113000679.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance

User Image DonCorleone77 Posted - 2 weeks ago

$RVVTF $PHRRF Revive provides update on psilocybin study for methamphetamine use disorder Revive Therapeutics (RVVTF) provides an update on the Company's clinical study evaluating the safety and feasibility of oral psilocybin as a potential treatment for methamphetamine use disorder conducted under an investigator-initiated IND at the University of Wisconsin-Madison, School of Medicine and Public Health and School of Pharmacy. The Study has enrolled nearly 50% of its intended study sample, with initial efficacy being encouraging. The clinical data generated from the Study may provide proprietary and valuable information on the safety, efficacy and dosing of oral psilocybin to support a potential pivotal clinical study and commercial initiatives in countries, such as Australia, where psilocybin can be available to licensed psychiatrists to prescribe for certain conditions. In addition, the Company will have exclusive access to key intellectual property from this Study....

User Image Mystockdaily Posted - 2 weeks ago

$RVVTF loading zone.

User Image 2014shelby Posted - 03/27/24

$RVVTF https://www.globenewswire.com/news-release/2024/03/27/2853251/0/en/Revive-Therapeutics-Submits-Type-C-Meeting-Request-Package-to-FDA-for-Clinical-Study-of-Bucillamine-to-Treat-Long-COVID.html

User Image Myturn Posted - 03/22/24

@tellurider The Bucillamine drug of $RVVTF could possibly treat the brain inflammation cause of long Covid. Still to be FDA Phase 2/3 tested to confirm

User Image Amessagefromtheodd Posted - 03/21/24

$RVVTF Why isn’t this biotech company- partnership with Barda PNG or a member of that flagship research group.

User Image nostraanus Posted - 03/19/24

$RVVTF

User Image eon1111 Posted - 03/19/24

@aa906814 $MNMD $NUMIF $CYBN $TRUFF $RVVTF

User Image SUPERKKING Posted - 03/19/24

$RVVTF

User Image SUPERKKING Posted - 03/19/24

$RVVTF https://www.globenewswire.com/en/news-release/2024/03/19/2848420/0/en/Revive-Therapeutics-To-Submit-Type-C-Meeting-Request-with-FDA-for-Bucillamine-to-Treat-Long-COVID.html

User Image SUPERKKING Posted - 4 weeks ago

$RVVTF

User Image ResearchTrd Posted - 4 weeks ago

$RVVTF BULLISH LATEST CORP REPORT : LONG COVID: " expects to submit it by the end of March 2024. The proposed Phase 2 clinical study is expected to be approved by the FDA in Q2-2024."

User Image nostraanus Posted - 1 month ago

$RVVTF

User Image SUPERKKING Posted - 1 month ago

$RVVTF

User Image Mystockdaily Posted - 1 month ago

$RVVTF Overdue breakout on watch

User Image Hiimbill Posted - 1 month ago

$RVVTF the definition of moron!

User Image SUPERKKING Posted - 1 month ago

$RVVTF

User Image Bull80 Posted - 1 month ago

$RVVTF Ok, this PR makes sense. Lot of things in pipeline. I hope and wish we see those 40 cents+ days again soon.

User Image SUPERKKING Posted - 1 month ago

$RVVTF

User Image Mikebets Posted - 1 month ago

$RVVTF News! Revive Therapeutics Provides Corporate Update The Company, under its wholly-owned subsidiary Revive Diagnostics Inc., is advancing the product development of a potential blood biomarker diagnostic that characterizes long COVID. https://www.globenewswire.com/news-release/2024/03/12/2844382/0/en/Revive-Therapeutics-Provides-Corporate-Update.html

User Image Mystockdaily Posted - 1 month ago

$RVVTF Breaking News! Revive Therapeutics Provides Corporate Update https://www.globenewswire.com/news-release/2024/03/12/2844382/0/en/Revive-Therapeutics-Provides-Corporate-Update.html

User Image FrozenFeathers Posted - 1 month ago

$RVVTF so sad to look at this smh

User Image TheDudeAb1des Posted - 1 month ago

$RVVTF Wank Sokâ„¢

User Image Amessagefromtheodd Posted - 1 month ago

$RVVTF The Food and Drug Administration (FDA) has expanded the approval of Veklury® (remdesivir) to include the treatment of COVID-19 in pediatric patients from birth to less than 28 days of age weighing at least 1.5kg to less than 3kg. https://www.empr.com/home/news/veklury-approval-expanded-to-include-covid-19-treatment-in-younger-children/

User Image fcollage Posted - 1 month ago

$RVVTF REVIVE THERAPEUTICS Corporate Presentation February 2024 https://revivethera.com/wp-content/uploads/2024/03/RVV-Deck-February-2024c.pdf